Senseonics Holdings, Inc. (SENS)
NASDAQ: SENS · Real-Time Price · USD
7.24
-0.19 (-2.56%)
Jun 10, 2026, 1:10 PM EDT - Market open
Senseonics Holdings Revenue
Senseonics Holdings had revenue of $11.71M in the quarter ending March 31, 2026, with 87.17% growth. This brings the company's revenue in the last twelve months to $40.71M, up 71.91% year-over-year. In the year 2025, Senseonics Holdings had annual revenue of $35.26M with 56.89% growth.
Revenue (ttm)
$40.71M
Revenue Growth
+71.91%
P/S Ratio
10.76
Revenue / Employee
$271,208
Employees
130
Market Cap
377.95M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 35.26M | 12.79M | 56.89% |
| Dec 31, 2024 | 22.47M | 82.00K | 0.37% |
| Dec 31, 2023 | 22.39M | 6.00M | 36.62% |
| Dec 31, 2022 | 16.39M | 2.71M | 19.85% |
| Dec 31, 2021 | 13.68M | 8.73M | 176.32% |
| Dec 31, 2020 | 4.95M | -16.35M | -76.77% |
| Dec 31, 2019 | 21.30M | 2.39M | 12.63% |
| Dec 31, 2018 | 18.91M | 12.54M | 196.77% |
| Dec 31, 2017 | 6.37M | - | - |
| Dec 31, 2016 | - | - | - |
| Dec 31, 2015 | - | - | - |
| Dec 31, 2014 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Orthofix Medical | 825.37M |
| Viemed Healthcare | 286.57M |
| Pacific Biosciences of California | 160.03M |
| Delcath Systems | 90.44M |
| Standard BioTools | 86.26M |
| Electromed | 71.75M |
| 908 Devices | 57.80M |
| ClearPoint Neuro | 40.61M |
SENS News
- 2 days ago - Senseonics announces further data from study of Eversense 365 - TheFly
- 4 days ago - Senseonics Holdings Transcript: Investor update - Transcripts
- 9 days ago - Senseonics Highlights Analyst Event and Oral Presentation of Eversense 365 Real-World Evidence at ADA 2026 - GlobeNewsWire
- 21 days ago - Senseonics Holdings Transcript: AGM 2026 - Transcripts
- 4 weeks ago - Senseonics price target lowered to $14 from $18.50 at H.C. Wainwright - TheFly
- 4 weeks ago - Senseonics price target lowered to $8 from $9 at Stifel - TheFly
- 4 weeks ago - Senseonics price target lowered to $12 from $20 at Lake Street - TheFly
- 4 weeks ago - Senseonics reports Q1 EPS (71c), consensus (70c) - TheFly